KRAS and cancer: Further investigation will be needed to characterize LYZ+ cancer cells with Paneth cell properties observed in colon cancers carrying mutations in Apc, Kras and Tp53 genes compared to normal Paneth cells in order to identify their roles in cancer stem cell niche development.